Organovo On Track to Establish Human 3D Disease Model in Inflammatory Bowel Disease in 2022
November 30, 2021 08:05 ET
|
Organovo, Inc.
SAN DIEGO, Nov. 30, 2021 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (Nasdaq: ONVO), today provided a business overview and progress update, and announced it is on track to establish its first...
Organovo Announces Adjournment of Annual Meeting of Shareholders Due to Lack of Quorum
September 17, 2021 16:10 ET
|
Organovo, Inc.
SOLANA BEACH, Calif., Sept. 17, 2021 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (Nasdaq: ONVO), today announced that the Company’s annual meeting of shareholders, on September 14, 2021, at 9:00...
Organovo Announces Participation at the H.C. Wainwright Global Life Sciences Conference March 9-10 2021 (VIRTUAL CONFERENCE)
March 02, 2021 08:05 ET
|
Organovo, Inc.
SOLANA BEACH, Calif., March 02, 2021 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (Nasdaq: ONVO), today announced it will be featured as a presenting company at the H.C. Wainwright Global Life...
Organovo Regains Compliance with Nasdaq Minimum Bid Price Requirement
September 03, 2020 16:05 ET
|
Organovo, Inc.
SAN DIEGO, Sept. 03, 2020 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (“Organovo” or the “Company”) (Nasdaq: ONVO) announced today that it has regained compliance with the minimum bid price...
Organovo Announces One-for-Twenty Reverse Stock Split
August 17, 2020 08:05 ET
|
Organovo, Inc.
SAN DIEGO, Aug. 17, 2020 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (the “Company”) (Nasdaq: ONVO) today announced that it filed a certificate of second amendment to its certificate of...
Organovo Acknowledges Receipt of Proposal
October 02, 2019 19:31 ET
|
Organovo, Inc.
SAN DIEGO, Oct. 02, 2019 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ: ONVO) (“Organovo”) today confirmed that it has received a proposal from Viscient Biosciences (“Viscient”), an...
Organovo to Explore Strategic Alternatives and Implement Restructuring Plan
August 07, 2019 09:00 ET
|
Organovo, Inc.
SAN DIEGO, Aug. 07, 2019 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ:ONVO) (“Organovo”) today announced that it has engaged Roth Capital Partners (“Roth”) as its financial advisor to assist...
Organovo Announces Release Date for Fiscal First-Quarter 2020 Financial Results
July 18, 2019 08:05 ET
|
Organovo, Inc.
SAN DIEGO, July 18, 2019 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ:ONVO) (“Organovo”) will host a conference call on Thursday, August 8, 2019 at 5:00 p.m. Eastern Time (ET) to discuss the...
Organovo Presents Data on Creating Stem Cell-Based Bioprinted Kidney Organoids at the International Society for Stem Cell Research (ISSCR) 2019 Annual Meeting
July 08, 2019 08:05 ET
|
Organovo, Inc.
SAN DIEGO, July 08, 2019 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ:ONVO) (“Organovo”), a biotechnology company pioneering the development of 3D bioprinted tissues aimed at treating a range...
Organovo to Present at Raymond James Life Sciences and MedTech Conference
June 13, 2019 08:05 ET
|
Organovo, Inc.
SAN DIEGO, June 13, 2019 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ:ONVO) (“Organovo”), a biotechnology company pioneering the development of 3D bioprinted tissues aimed at treating a range...